Novartis pays over $700m to settle US kickbacks case
Swiss pharmaceutical giant Novartis will pay some $729 million to settle a lawsuit brought by Washington accusing it of paying kickbacks to doctors, among other allegations.
Jul 2, 2020
0
6
Swiss pharmaceutical giant Novartis will pay some $729 million to settle a lawsuit brought by Washington accusing it of paying kickbacks to doctors, among other allegations.
Jul 2, 2020
0
6
Is the basic research that goes into the development of new drugs more efficiently conducted by public-sector scientists, pharmaceutical firms, or independent private laboratories? What role do each of these groups play in ...
Jun 29, 2020
0
2
New research suggests targeting the spike proteins could provide an effective treatment for SARS-CoV-2(COVID-19) and provide valuable structural data for teams working to develop vaccines against it.
Jun 26, 2020
0
29
During the next year, the Food and Drug Administration will review many new drug applications for preventing and treating the new coronavirus. But early approvals could get delayed by the standards the agency used for older ...
Jun 19, 2020
1
45
A company targeted by the Food and Drug Administration for selling unauthorized coronavirus antibody tests says it has responded to regulators' concerns, though it has no business operations in the U.S.
Jun 18, 2020
0
0
Nearly 9 in 10 U.S. adults are "very" (55%) or "somewhat" (33%) concerned that the pharmaceutical industry will leverage the COVID-19 pandemic to raise drug prices. Similarly, 84% are very or somewhat concerned that the general ...
Jun 18, 2020
0
1
It's not uncommon for U.S. pharmaceutical companies to pay medical doctors to promote their medications. Questions over possible conflicts of interest have led to introduction of laws that require payment disclosure so that ...
Jun 8, 2020
0
2
The US Justice Department sued a Chinese company for selling nearly a half million fake and substandard N95 respirator to US buyers in April as the COVID-19 pandemic swept the country.
Jun 6, 2020
0
136
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19.
Jun 1, 2020
0
2
Bonnie Robeson, a senior lecturer at the Johns Hopkins Carey Business School, knows what it's like to take part in an urgent race to find a vaccine or treatment for a lethal malady, such as the current effort to contain the ...
May 29, 2020
0
2